250 related articles for article (PubMed ID: 29066236)
1. Translational gap in ongoing clinical trials for glioma.
Guishard AF; Yakisich JS; Azad N; Iyer AKV
J Clin Neurosci; 2018 Jan; 47():28-42. PubMed ID: 29066236
[TBL] [Abstract][Full Text] [Related]
2. Translational gap in glioma research.
Ma C; Zhao G; Cruz MH; Siden A; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1110-20. PubMed ID: 25175687
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells.
Li XT; Ju RJ; Li XY; Zeng F; Shi JF; Liu L; Zhang CX; Sun MG; Lou JN; Lu WL
Oncotarget; 2014 Aug; 5(15):6497-511. PubMed ID: 25153726
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
[TBL] [Abstract][Full Text] [Related]
5. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
Zhu X; Fang Y; Chen Y; Chen Y; Hong W; Wei W; Tu J
Life Sci; 2023 May; 320():121558. PubMed ID: 36889666
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
Zhang F; Xu CL; Liu CM
Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
[TBL] [Abstract][Full Text] [Related]
8. Lipid vesicles containing transferrin receptor binding peptide TfR-T
Mu LM; Bu YZ; Liu L; Xie HJ; Ju RJ; Wu JS; Zeng F; Zhao Y; Zhang JY; Lu WL
Sci Rep; 2017 Jun; 7(1):3487. PubMed ID: 28615716
[TBL] [Abstract][Full Text] [Related]
9. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma.
Wang Y; Huang N; Li H; Liu S; Chen X; Yu S; Wu N; Bian XW; Shen HY; Li C; Xiao L
Oncotarget; 2017 Jun; 8(23):37511-37524. PubMed ID: 28415586
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
[TBL] [Abstract][Full Text] [Related]
11. siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines.
Song Y; Mu L; Han X; Liu X; Fu S
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1034-40. PubMed ID: 25348735
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Drug Screening in Patient-Derived IDH
Dao Trong P; Jungwirth G; Yu T; Pusch S; Unterberg A; Herold-Mende C; Warta R
Cells; 2020 Jun; 9(6):. PubMed ID: 32503220
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
15. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
16. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.
Cao Y; Tsien CI; Shen Z; Tatro DS; Ten Haken R; Kessler ML; Chenevert TL; Lawrence TS
J Clin Oncol; 2005 Jun; 23(18):4127-36. PubMed ID: 15961760
[TBL] [Abstract][Full Text] [Related]
17. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
18. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
[TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
Shi L; Sun G; Zhu H
Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
